Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Mental Health 2003;6:94; doi:10.1136/ebmh.6.3.94
Copyright © 2003 by BMJ Publishing Group Ltd, Royal College of Psychiatrists, & British Psychological Society.
Evidence-Based Mental Health 2003; 6:94
© 2003 BMJ Publishing Group Ltd., Royal College of Psychiatrists, & British Psychological Society

Therapeutics

Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer’s disease

Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 2003 Jan;280:210–6

QUESTION: How effective are cholinesterase inhibitors for neuropsychiatric and functional outcomes in people with mild to moderate Alzheimer’s disease?

The first 150 words of the full text of this article appear below.

Design

Systematic review with meta-analysis.

Data sources

The authors searched Medline, Dissertations Abstracts, PsychInfo, Biosis, Pubmed, and the Cochrane Controlled Trials Register through December 2001; examined bibliographies of reviews, original research articles, and other articles of interest; and contacted researchers and pharmaceutical companies for additional studies.

Study selection

Published and unpublished double blind randomised trials in any language were eligible if they focused on outpatients diagnosed with mild to moderate probable Alzheimer’s disease who were treated for at least one month with a cholinesterase inhibitor. 29 parallel group placebo controlled trials were included.

Data extraction

Two reviewers extracted data independently about study methods, sources of bias, and outcomes. Sixteen trials included neuropsychiatric outcomes and 18 included functional measures. Neuropsychiatric outcomes were measured with the Neuropsychiatric Inventory (NPI) and the Alzheimer Disease Assessment Scale, non-cognitive (ADAS-noncog). Data were combined using weighted mean differences. Functional outcomes were measured with activities of daily living and instrumental activities of daily living . . . [Full text of this article]

Debomoy K Lahiri, Martin R Farlow, MD, PhD

Departments of Psychiatry and Neurology
Institute of Psychiatric Research
Indiana University School of Medicine
Indianapolis, Indiana, USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Online Education

Psychiatry CPD/CME from The Royal College of Psychiatrists

Professional Development from The British Psychological Society